Novel Laboratories, Inc. FDA Record
- Latest inspection VAI · Apr 17, 2026
- No warning letters matched by name
Novel Laboratories, Inc. has 3 FDA recalls, 16 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Novel Laboratories, Inc." is on file.
- Latest recall
- D-0599-2018 · Class III · Mar 5, 2018
- Latest inspection
- Apr 17, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 16 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Novel Laboratories, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 1 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 2 | 0 | 0 | 1 | 0 |
| 2017 | 2 | 0 | 0 | 1 | 0 |
Reviewing Novel Laboratories, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Novel Laboratories, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0599-2018 | Class III | Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets… | Mar 5, 2018 |
| D-0653-2017 | Class III | Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use, 60… | Feb 22, 2017 |
| D-1484-2014 | Class III | Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for… | Jun 20, 2014 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 17, 2026 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Oct 10, 2025 | Somerset, NJ | Devices | Voluntary Action Indicated (VAI) | 3006271438 |
| May 17, 2024 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3006271438 |
| Jan 13, 2023 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Mar 30, 2022 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Nov 5, 2020 | Somerset, NJ | Drugs | Official Action Indicated (OAI) | 3006271438 |
| Nov 8, 2018 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Feb 23, 2018 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Aug 8, 2017 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Feb 14, 2017 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3006271438 |
| Nov 17, 2015 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3006271438 |
| Jan 22, 2015 | Somerset, NJ | Drugs | No Action Indicated (NAI) | 3006271438 |
| Jun 24, 2014 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Aug 26, 2013 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Jun 29, 2011 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
| Mar 5, 2010 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3006271438 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006271438 | Somerset, NJ | 16 | Apr 17, 2026 |
Novel Laboratories, Inc. and the FDA: common questions
Has Novel Laboratories, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Novel Laboratories, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Novel Laboratories, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Novel Laboratories, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Novel Laboratories, Inc.?
The most recent FDA inspection on file ended Apr 17, 2026 at Somerset, NJ and was classified VAI. FDA has 16 inspections of Novel Laboratories, Inc. on file, 1 of them classified OAI (official action indicated).
Has Novel Laboratories, Inc. had an FDA recall?
Yes. Novel Laboratories, Inc. has 3 FDA recalls on record. The most recent started Mar 5, 2018.
Need more than this page shows? Ask about Novel Laboratories, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.